Al18F-NOTA-Octreotide PET/CT and 18F-FDG PET/CT for Detecting Cerebellar Hemangioblastoma in a Patient With Von Hippel-Lindau Disease.

MLA

Guozhu Hou, et al. “Al18F-NOTA-Octreotide PET/CT and 18F-FDG PET/CT for Detecting Cerebellar Hemangioblastoma in a Patient With Von Hippel-Lindau Disease.” Clinical Nuclear Medicine, vol. 49, no. 3, Mar. 2024, pp. 289–91. EBSCOhost, https://doi.org/10.1097/RLU.0000000000005042.

APA

Guozhu Hou, Xin Cheng, Yihebali Chi, Xuejuan Wang, & Rong Zheng. (2024). Al18F-NOTA-Octreotide PET/CT and 18F-FDG PET/CT for Detecting Cerebellar Hemangioblastoma in a Patient With Von Hippel-Lindau Disease. Clinical Nuclear Medicine, 49(3), 289–291. https://doi.org/10.1097/RLU.0000000000005042

Chicago

Guozhu Hou, Xin Cheng, Yihebali Chi, Xuejuan Wang, and Rong Zheng. 2024. “Al18F-NOTA-Octreotide PET/CT and 18F-FDG PET/CT for Detecting Cerebellar Hemangioblastoma in a Patient With Von Hippel-Lindau Disease.” Clinical Nuclear Medicine 49 (3): 289–91. doi:10.1097/RLU.0000000000005042.